139 related articles for article (PubMed ID: 26235677)
1. Pharmacogenomics of long-acting β2-agonists.
Blake K; Lima J
Expert Opin Drug Metab Toxicol; 2015; 11(11):1733-51. PubMed ID: 26235677
[TBL] [Abstract][Full Text] [Related]
2. Controversies regarding long-acting β2-agonists.
Khianey R; Oppenheimer J
Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):345-54. PubMed ID: 21659855
[TBL] [Abstract][Full Text] [Related]
3. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
[TBL] [Abstract][Full Text] [Related]
4. The use of inhaled formoterol in the treatment of asthma.
Berger WE
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
[TBL] [Abstract][Full Text] [Related]
6. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
Prenner BM
Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of β2-agonists.
Hizawa N
Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
[TBL] [Abstract][Full Text] [Related]
8. Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort.
Zuurhout MJ; Vijverberg SJ; Raaijmakers JA; Koenderman L; Postma DS; Koppelman GH; Maitland-van der Zee AH
Pharmacogenomics; 2013 Dec; 14(16):1965-71. PubMed ID: 24279851
[TBL] [Abstract][Full Text] [Related]
9. Assessing the viability of long-acting β
Matera MG; Rinaldi B; Calzetta L; Cazzola M
Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):129-136. PubMed ID: 27615145
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic tests in asthma therapy.
Yu IW; Bukaveckas BL
Clin Lab Med; 2008 Dec; 28(4):645-65. PubMed ID: 19059068
[TBL] [Abstract][Full Text] [Related]
11. What is new with the beta2-agonists: issues in the management of asthma.
Kelly HW
Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
[TBL] [Abstract][Full Text] [Related]
12. LABAs in asthmatic children: highlights and new inside.
Miraglia del Giudice M; Matera MG; Capristo C; Conte M; Santaniello F; Chinellato I; Leonardi S; Miraglia del Giudice MC; Perrone L
Pulm Pharmacol Ther; 2013 Oct; 26(5):540-3. PubMed ID: 23583567
[TBL] [Abstract][Full Text] [Related]
13. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of different long-acting β2-agonists combined with inhaled glucocorticoid regimens in patients with asthma: a network meta-analysis.
Tang Y; Zhang C; Zhang Z; Tian J
J Asthma; 2019 Nov; 56(11):1159-1171. PubMed ID: 30359144
[No Abstract] [Full Text] [Related]
15. Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management.
Ortega VE
Clin Genet; 2014 Jul; 86(1):12-20. PubMed ID: 24641588
[TBL] [Abstract][Full Text] [Related]
16. Concerns with beta2-agonists in pediatric asthma - a clinical perspective.
Kersten ET; Koppelman GH; Thio BJ
Paediatr Respir Rev; 2017 Jan; 21():80-85. PubMed ID: 27515731
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
[TBL] [Abstract][Full Text] [Related]
18. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
19. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
Chung LP; Waterer G; Thompson PJ
Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
